PASQUESI JOHN M

Director Pasquesi sold 212.7K shares at blended $93.91 for $20.0M, reducing stake 42.3%

John M Pasquesi, a director of Arch Capital Group, executed three separate sales totaling 212,666 shares for $19,970,730.82 on 2025-12-12 and 2025-12-15, at prices between $93.81 and $94.17. This represents a significant reduction of 42.3% from his pre-transaction holdings of 502,222 shares, leaving him with 289,556 shares post-sale. Pasquesi's prior trades at ACGL show a pattern of well-timed selling: both previous sales (on 2025-05-13 and 2025-05-12) resulted in negative 90-day returns of -3.0% and -5.1% respectively, indicating the stock declined after those sales. His cross-ticker track record (2 prior sales across all tickers) shows a 100.00% well-timed rate at the 90-day mark, with an average 90-day return of -5.3%. The current stock price of $95.58 is at -1.4% from the 52-week high and has appreciated +3.3% over 30 days and +9.4% over 90 days since the transaction. The company's fundamentals remain solid with P/E of 8.46, annual revenue growth of +27.9%, and latest quarterly net income of $1,350,000,000.00. The large concentrated sale by a board-level insider at valuations near 52-week highs, combined with his demonstrated pattern of well-timed exits at this ticker, warrants attention but does not contradict the company's strong operational trajectory.

Director Pasquesi sells 99,056 shares at $94.01–$94.72 for $9.3M, reducing stake from 654.3K to 555.2K shares (-15.1%)

John M Pasquesi, a director of Arch Capital Group, executed 2 separate sales totaling 99,056 shares for $9,328,999.85 at prices ranging $94.01–$94.72 on May 12–13, 2025, reducing his post-transaction holdings to 555,222 shares from a prior 654,278 shares. The blended average sale price of $94.18 was above current price of $90.85, though below the 52-week high of $114.86. The magnitude represents a material -15.1% reduction in his stake, occurring as the stock is down 20.9% from its 52-week high and trading near its lower quartile within the 52-week range. Arch Capital's fundamentals show solid execution: $4.7B quarterly revenue, net income of $574.0M, annual revenue growth of +27.9%, and a low P/E of 9.04, suggesting the company is operationally healthy and trading at reasonable valuation multiples. The sale's timing relative to recent price action and the company's strong financial metrics bears monitoring to understand the director's view of forward valuations versus current levels.